1. Pink Sheet
  2. >>Compliance
  3. >>Marketing & Advertising

US FDA’s Rx Drug Promo Study Answers $798,000 Question

 
• By Brenda Sandburg

Viewers spend more time on print ads that have more lengthy important safety information or a brief summary but impact on understanding is unclear, OPDP study finds. Another study finds exaggerated images of drug benefits in TV ads unsurprisingly can mislead consumers.

advertisement_viewing
Exaggerated images of drug benefits in TV ads can mislead consumers • Source: Shutterstock

A US Food and Drug Administration study found that consumers viewing Rx drug print ads fixate for a longer period of time on those that have more lengthy important safety information or a brief summary.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Marketing & Advertising

More from Compliance